Prof Anna Martling presented results of #ALASCCA trial at #ASCOGI25, showing low dose aspirin reduce the recurrence rate by 50% in CRC-patients with tumors having mutations in the PI3K pathway. Proud of taking part in this trial with my team at Helsinki University Hospital, Colorectal Unit